A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts
Status:
Terminated
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effect of 400 mg of oral zinc gluconate on
genital warts. Our hypothesis is that there will be a 10% difference in complete clearance of
genital warts in the group randomized to oral plus standard of care compared to those
randomized to placebo plus standard of care.